Detailed information for compound 420371

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 350.322 | Formula: C20H14O6
  • H donors: 2 H acceptors: 4 LogP: 4.15 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC(=O)c1c(O)ccc2c1oc(c2)c1coc2c1ccc(c2C(=O)C)O
  • InChi: 1S/C20H14O6/c1-9(21)17-14(23)5-3-11-7-16(26-19(11)17)13-8-25-20-12(13)4-6-15(24)18(20)10(2)22/h3-8,23-24H,1-2H3
  • InChiKey: GRJLOMBLCIZOQH-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Loa Loa (eye worm) AMP-binding enzyme family protein 0.0125 0.4155 0.4782
Mycobacterium tuberculosis Phenolpthiocerol synthesis type-I polyketide synthase PpsC 0.0134 0.4555 0.5856
Mycobacterium tuberculosis Probable polyketide synthase Pks7 0.0142 0.4933 0.6376
Brugia malayi Beta-ketoacyl synthase, N-terminal domain containing protein 0.0134 0.4555 0.4555
Brugia malayi AMP-binding enzyme family protein 0.0125 0.4155 0.4155
Mycobacterium leprae Probable polyketide synthase Pks1 0.0142 0.4933 0.6337
Mycobacterium tuberculosis Probable polyketide synthase Pks5 0.013 0.4368 0.5599
Wolbachia endosymbiont of Brugia malayi 3-oxoacyl-ACP synthase 0.0034 0 0.5
Mycobacterium tuberculosis Polyketide synthase Pks2 0.013 0.4368 0.5599
Loa Loa (eye worm) acyl carrier protein 0.0062 0.127 0.1462
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE 0.0089 0.2495 0.2941
Mycobacterium tuberculosis Probable polyketide synthase Pks15 0.0054 0.0933 0.0864
Chlamydia trachomatis 3-oxoacyl-ACP synthase 0.0034 0 0.5
Mycobacterium tuberculosis Polyketide synthase Pks13 0.02 0.7562 1
Mycobacterium tuberculosis Probable fatty acid synthase Fas (fatty acid synthetase) 0.0042 0.0384 0.0108
Mycobacterium tuberculosis Probable thioesterase TesA 0.0112 0.3541 0.4459
Mycobacterium leprae Polyketide synthase Pks13 0.02 0.7562 1
Mycobacterium tuberculosis Probable multifunctional mycocerosic acid synthase membrane-associated Mas 0.0142 0.4933 0.6376
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB 0.0108 0.3367 0.4155
Mycobacterium tuberculosis Phenolpthiocerol synthesis type-I polyketide synthase PpsA 0.0134 0.4555 0.5856
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsB 0.0108 0.3367 0.4452
Mycobacterium ulcerans thioesterase TesA 0.0112 0.3541 0.4682
Mycobacterium ulcerans polyketide synthase 0.0134 0.4555 0.6023
Onchocerca volvulus Fatty acid synthase homolog 0.0242 0.9436 1
Schistosoma mansoni methyltransferase-related 0.004 0.0306 1
Trypanosoma cruzi beta-ketoacyl synthase family protein, putative 0.0034 0 0.5
Mycobacterium ulcerans polyketide synthase 0.0142 0.4933 0.6522
Brugia malayi AMP-binding enzyme family protein 0.0041 0.0343 0.0343
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC 0.0142 0.4933 0.6337
Mycobacterium ulcerans Type I modular polyketide synthase 0.0134 0.4555 0.6023
Toxoplasma gondii AMP-binding enzyme domain-containing protein 0.0068 0.1547 0.3136
Mycobacterium leprae PROBABLE THIOESTERASE TESA 0.0112 0.3541 0.4398
Mycobacterium tuberculosis Polyketide synthetase MbtD (polyketide synthase) 0.0041 0.0343 0.0052
Mycobacterium ulcerans Type I modular polyketide synthase 0.0134 0.4555 0.6023
Toxoplasma gondii type I fatty acid synthase, putative 0.0142 0.4933 1
Loa Loa (eye worm) fatty acid synthase 0.0132 0.4474 0.5149
Mycobacterium ulcerans multifunctional mycocerosic acid synthase membrane-associated Mas 0.0142 0.4933 0.6522
Mycobacterium tuberculosis Probable membrane bound polyketide synthase Pks6 0.02 0.7562 1
Mycobacterium ulcerans fatty acid synthase Fas 0.0042 0.0384 0.0508
Toxoplasma gondii type I fatty acid synthase, putative 0.0095 0.2802 0.5682
Mycobacterium tuberculosis Polyketide synthetase MbtC (polyketide synthase) 0.0046 0.0564 0.0356
Mycobacterium ulcerans thioesterase 0.0112 0.3541 0.4682
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD 0.0134 0.4555 0.581
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsA 0.0108 0.3367 0.4452
Toxoplasma gondii beta-ketoacyl synthase, N-terminal domain-containing protein 0.0087 0.2419 0.4903
Trypanosoma brucei beta-ketoacyl-ACP synthase 0.0034 0 0.5
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA 0.0134 0.4555 0.581
Mycobacterium ulcerans polyketide synthase Pks13 0.02 0.7562 1
Mycobacterium tuberculosis Probable polyketide synthase Pks8 0.011 0.3447 0.4329
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsE 0.0089 0.2495 0.3299
Plasmodium vivax 3-oxoacyl-[acyl-carrier-protein] synthase i/ii, putative 0.0034 0 0.5
Leishmania major hypothetical protein, conserved 0.004 0.0306 1
Mycobacterium tuberculosis Phenolpthiocerol synthesis type-I polyketide synthase PpsD 0.0134 0.4555 0.5856
Mycobacterium tuberculosis Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) 0.0125 0.4155 0.5305
Echinococcus granulosus 3 oxoacyl acyl carrier protein synthase 0.0034 0 0.5
Mycobacterium tuberculosis Polyketide synthase Pks12 0.0142 0.4933 0.6376
Mycobacterium ulcerans polyketide synthase Pks9 0.0089 0.2495 0.3299
Plasmodium falciparum 3-oxoacyl-acyl-carrier protein synthase I/II 0.0034 0 0.5
Brugia malayi Methyltransferase-like protein 4 0.004 0.0306 0.0306
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsD 0.0134 0.4555 0.6023
Mycobacterium tuberculosis Probable polyketide synthase Pks9 0.0076 0.1931 0.224
Onchocerca volvulus 0.0233 0.9058 0.9285
Trypanosoma cruzi beta-ketoacyl synthase family protein, putative 0.0034 0 0.5
Trichomonas vaginalis conserved hypothetical protein 0.004 0.0306 0.5
Mycobacterium ulcerans polyketide synthase MbtD 0.0041 0.0343 0.0454
Giardia lamblia Methyltransferase like 2 0.004 0.0306 0.5
Loa Loa (eye worm) hypothetical protein 0.0075 0.1881 0.2164
Mycobacterium tuberculosis Probable polyketide synthase Pks1 0.0096 0.2842 0.3495
Mycobacterium ulcerans Type I modular polyketide synthase 0.0134 0.4555 0.6023
Mycobacterium leprae Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas 0.0142 0.4933 0.6337
Echinococcus multilocularis 3 oxoacyl (acyl carrier protein) synthase 0.0034 0 0.5
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsC 0.0142 0.4933 0.6522
Loa Loa (eye worm) hypothetical protein 0.0225 0.869 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 56.3 uM Inhibition of PTP1B in presence of 0.01% Triton X-100 ChEMBL. 17095232
IC50 (binding) = 56.3 uM Inhibition of PTP1B in presence of 0.01% Triton X-100 ChEMBL. 17095232
IC50 (binding) = 75 uM Inhibition of PTP1B ChEMBL. 17095232
IC50 (binding) = 75 uM Inhibition of PTP1B ChEMBL. 17095232
Inhibition (binding) = 72 % Inhibition of PTP1B at 100 uM ChEMBL. 17095232
Inhibition (binding) = 72 % Inhibition of PTP1B at 100 uM ChEMBL. 17095232
Ki (binding) = 54 uM Inhibition of PTP1B in presence of 0.01% Triton X-100 ChEMBL. 17095232
Ki (binding) = 54 uM Inhibition of PTP1B in presence of 0.01% Triton X-100 ChEMBL. 17095232
Ki (binding) = 64 uM Inhibition of PTP1B ChEMBL. 17095232
Ki (binding) = 64 uM Inhibition of PTP1B ChEMBL. 17095232

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.